A global pharmaceutical company earned the top spot in the biotech sector on the 2022 S&P Corporate Sustainability Assessment (Data as on - Dec 12, 2022).
The company has been named to the Dow Jones Sustainability World Index (DJSI World) and Dow Jones Sustainability North America Index (DJSI North America) for the tenth consecutive year.
S&P identifies global sustainability leaders through its Corporate Sustainability Assessment (CSA) and compiles the Dow Jones Sustainability World Index.
The pharma company's 2021 ESG (Environmental, Social, and Governance) report states: It achieved a 25% emissions reduction in 2021, four years ahead of schedule, by increasing investment in renewable resources. It cut its waste to landfill by 92%.
Its patient assistance program provided more than 170 thousand patients with free medicines. It donated around $ 1.2 million to disaster relief organizations.
